Aya Nakae, Hani M Bu-Omer, Wei-Chuan Chang, Chie Kishimoto, Yuya Onishi, Hidenobu Sumioka, Masahiro Shiomi
Pain management is a critical challenge in healthcare, often exacerbated by loneliness and emotional distress. This study investigated the potential of a communication robot, Moffuly, to reduce pain perception and influence hormonal responses in a controlled experimental setting. Nineteen healthy participants underwent heat pain stimulation under two conditions: with and without robotic interaction. Pain levels were assessed using the Short-form McGill Pain Questionnaire and the Visual Analogue Scale, while mood and mental states were evaluated through established questionnaires including the Profile of Mood States, Hospital Anxiety and Depression Scale, and Self-Rating Depression Scale. Hormonal changes, including cortisol, growth hormone, oxytocin, estradiol, and dehydroepiandrosterone-sulfate, were measured from blood samples collected at key time points. The results demonstrated significant reductions in subjective pain and improvements in mood following robotic interaction. These effects were accompanied by favorable hormonal changes, including increased oxytocin and decreased cortisol and growth hormone levels. The findings suggest that robotic interaction may serve as an innovative approach to pain management by addressing both physiological and psychological factors. This study highlights the potential of robotics to complement traditional therapies in alleviating pain and enhancing emotional well-being. By mitigating emotional distress and loneliness, robotic interventions may enhance existing pain therapies and offer innovative solutions for resource-limited healthcare systems.
J Pain. 2009 May;10(5):447-85
[PMID:
19411059]
J Am Geriatr Soc. 2021 Nov;69(11):3081-3091
[PMID:
34247388]
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
[PMID:
6880820]
Pain Res Manag. 2020 Apr 9;2020:7935215
[PMID:
32351642]
J Med Internet Res. 2021 Dec 30;23(12):e28022
[PMID:
34967760]
Nature. 2001 Sep 13;413(6852):203-10
[PMID:
11557989]
Evid Based Complement Alternat Med. 2013;2013:187182
[PMID:
23762107]
Neuroscience. 2011 Sep 15;191:91-100
[PMID:
21549182]
PLoS One. 2021 Dec 20;16(12):e0261570
[PMID:
34929017]
Lancet. 2021 May 29;397(10289):2082-2097
[PMID:
34062143]
J Pain. 2010 Feb;11(2):186-94
[PMID:
19853521]
Sensors (Basel). 2024 Nov 26;24(23):
[PMID:
39686077]
Annu Rev Clin Psychol. 2019 May 7;15:399-423
[PMID:
30786242]
Gerontologist. 2019 Jan 9;59(1):e37-e51
[PMID:
29897445]
Pain. 2016 Nov;157(11):2420-2423
[PMID:
27200490]
BMJ Open. 2018 Feb 12;8(2):e018815
[PMID:
29440212]
Arch Gen Psychiatry. 1965 Jan;12:63-70
[PMID:
14221692]
Pain. 2021 Mar 1;162(3):930-937
[PMID:
32960533]
Can J Nurs Res. 2020 Dec;52(4):328-334
[PMID:
31318580]
BMC Psychiatry. 2018 May 29;18(1):156
[PMID:
29843662]
Ann Rheum Dis. 2004 Apr;63(4):342-7
[PMID:
15020325]
Sci Rep. 2013 Oct 23;3:3034
[PMID:
24150186]
Neurosci Biobehav Rev. 2016 Sep;68:928-945
[PMID:
27377692]
Neuropeptides. 2020 Feb;79:101996
[PMID:
31776011]
J Interpers Violence. 2022 Mar;37(5-6):NP2516-NP2537
[PMID:
32713232]
PLoS One. 2023 Mar 7;18(3):e0280946
[PMID:
36881570]
Exp Gerontol. 2015 Aug;68:76-81
[PMID:
25300732]
Front Psychiatry. 2022 Oct 21;13:1003881
[PMID:
36339874]
Emerg Med J. 2001 May;18(3):205-7
[PMID:
11354213]
Psychol Bull. 2007 Jul;133(4):581-624
[PMID:
17592957]
Clin J Pain. 2014 May;30(5):453-62
[PMID:
23887343]
J Psychiatr Res. 2020 Nov;130:68-74
[PMID:
32791383]
Front Pharmacol. 2020 May 19;11:615
[PMID:
32508630]
PLoS One. 2023 May 23;18(5):e0286260
[PMID:
37220157]
Neuropsychopharmacology. 2013 Aug;38(9):1798-807
[PMID:
23552182]
Neuroscience. 2018 Sep 1;387:149-161
[PMID:
28965836]
J Physiol Sci. 2012 Nov;62(6):441-4
[PMID:
23007624]
Hormones (Athens). 2021 Dec;20(4):679-689
[PMID:
34195937]
Pain Med. 2020 Jan 1;21(1):21-31
[PMID:
30615177]
Disabil Rehabil Assist Technol. 2022 May;17(4):418-430
[PMID:
32643466]
Int J Mol Sci. 2023 Jan 18;24(3):
[PMID:
36768188]
Cell. 2009 Oct 16;139(2):267-84
[PMID:
19837031]
Int Psychogeriatr. 2020 Aug;32(8):981-991
[PMID:
32284080]
Pain Med. 2014 Nov;15(11):1930-7
[PMID:
24930826]
Pediatr Blood Cancer. 2018 Sep;65(9):e27242
[PMID:
29893482]
PLoS One. 2020 Jul 28;15(7):e0230992
[PMID:
32722725]
Psychol Aging. 2010 Jun;25(2):453-63
[PMID:
20545429]
Arch Fam Med. 2000 May;9(5):451-7
[PMID:
10810951]
Vaccine. 2013 Jun 7;31(25):2772-7
[PMID:
23623861]
Mol Psychiatry. 2021 Jan;26(1):218-233
[PMID:
32020048]
Pain. 2009 Jul;144(1-2):35-42
[PMID:
19356853]
Curr Robot Rep. 2022;3(4):271-280
[PMID:
36311256]
CJEM. 2021 Jan;23(1):85-93
[PMID:
33683608]
Phys Ther. 2014 Dec;94(12):1816-25
[PMID:
25035267]
J Am Med Dir Assoc. 2013 Sep;14(9):661-7
[PMID:
23545466]
Pain. 2009 Jul;144(1-2):28-34
[PMID:
19278785]
Exp Gerontol. 2011 Feb-Mar;46(2-3):90-5
[PMID:
20833240]
Pain. 2001 Nov;94(2):149-158
[PMID:
11690728]
Clin Interv Aging. 2021 May 24;16:941-971
[PMID:
34079242]
Biomed Res Int. 2022 Mar 9;2022:5667223
[PMID:
35309176]
MMWR Recomm Rep. 2022 Nov 04;71(3):1-95
[PMID:
36327391]
Eur J Endocrinol. 2019 Jul;181(1):R23-R43
[PMID:
31096185]
J Zhejiang Univ Sci B. 2019 Aug.;20(8):628-636
[PMID:
31273960]
Philos Trans R Soc Lond B Biol Sci. 2019 Apr 29;374(1771):20180034
[PMID:
30852995]
BMJ Open. 2018 Dec 14;8(12):e023366
[PMID:
30552264]
Biol Sex Differ. 2021 Feb 10;12(1):22
[PMID:
33568220]
Front Neurosci. 2021 Jun 24;15:661819
[PMID:
34248479]
Endocrinology. 2001 Nov;142(11):4589-94
[PMID:
11606422]
Pain Med. 2013 Apr;14(4):498-503
[PMID:
23137117]
Anesth Analg. 2007 Jul;105(1):205-21
[PMID:
17578977]